Skip to main content

Table 1 Viability of CD5+-cells after IL-3 withdrawal

From: Retroviral Vector Design for Gene Therapy of Cancer: Specific Inhibition and Tagging of BCR-ABLp190 Cells

Infected Cells

+IL-3

−IL-3

Ba/F3+p190 + MFGA190CD5

6.8%

0%

Ba/F3+p190 + MFGS190CD5

7.2%

7.2%

Ba/F3+p210 + MFGA190CD5

5.9%

5.9%

Back to article page

Molecular Medicine

ISSN: 1528-3658